Cognitive Remediation and Sheltered Employment in Schizophrenia

Not Applicable

Completed

• Conditions: Chronic Schizophrenia
• Interventions: Behavioral: RECOS (COgnitive REmediation for Schizophrenia); Behavioral: TAU (Treatment As Usual)

• Registration Number: NCT01891929
• Lead Sponsor: Hôpital le Vinatier

Brief Summary

This study, driven on schizophrenic patients, is aimed at :

1. Measuring the efficiency of the cognitive remediation program RECOS (COgnitive REmediation in Schizophrenia) on the capacity of the patients suffering from schizophrenia to improve the integration in sheltered employment (ESAT and EA).

2. Comparing the efficiency of the program of cognitive remediation RECOS (RECOS arm) to the one of an usual program of coverage/care (TAU arm = Treatment As Usual) on integration in sheltered employment of patients suffering from schizophrenia.

3. Realizing a comparative analysis, in both arms, of :

1. the number of working hours achieved in sheltered environment during the 6 months following the two programs (reported to the working time planned by the contract of employment)

2. the duration of such employments in sheltered areas.

4. Estimating the impact of RECOS on the neuropsychological variables, the symptomatology, the consciousness of the disorders(insight), the quality of life and the social autonomy before the treatment (month M0), at the end of the treatment (month M3), and 6 months later (month M9), and looking for a correlation between the improvement of these parameters and sheltered employment.

5. Estimating the impact of cognitive remediation on integration in sheltered employment.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2013-06-28
• Study First Submitted QC: 2013-06-28
• Study Start: 2013-07
• Study First Posted: 2013-07-03
• Primary Completion: 2018-10-22
• Study Completion: 2018-10-22
• Status Verified: 2019-02
• Last Update Submitted: 2019-02-22
• Last Update Posted: 2019-02-25

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 79

Inclusion Criteria

• Age from 18 to 50 years.
• Schizophrenia according to the criteria of the DSM-IV-TR.
• Project of entry to ESAT or to EA in the 6 weeks which follow.
• IQ > 70 (F-NART).
• Stable symptomatology during the month preceding the inclusion.
• Psychotropic treatment unchanged during the month preceding the inclusion (change no more than 25 % posology).
• Overdrawn performances in at least one of the 6 functions estimated by the kit of neuropsychological tests.
• French mother tongue.
• Informed and signed consent by the patient.
• Agreement of the guardian (for protected adults).
• Membership in a national insurance scheme.

Exclusion Criteria

• Dependence and recent abuses of cannabis (> 2 / week) or in any other substance (according to the criteria of the DSM-IV-TR), except tobacco.
• Neurological disorders of vascular, infectious or neurodegenerative origin; dyschromatopsie.
• Taking of medicine with somatic tropism having a cerebral or psychic impact (eg: corticoids).
• Simultaneous participation to any other program of remediation targeting the neurocognitive deficits.
• Resistance to neuroleptic.
• Reading and writing not acquired.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
RECOS	RECOS (COgnitive REmediation for Schizophrenia)	The RECOS program (COgnitive REmediation for Schizophrenia) was designed by SBT Company and adapted by Vianin et al (2007) for specific use in schizophrenia. It includes computer based and paper and pencil exercises that target 6 main cognitive functions (selective attention; verbal memory; visuo-spatiale attention and memory, working memory, reasoning, and speed of execution) which have been recommended by the MATRICS consensus. Each exercise has 10 difficulty levels. Allocation of the training modules in RECOS is determined according to the standard scores obtained in the comprehensive neuropsychological assessment. Each patient participates in the module corresponding to his/her most altered cognitive area.
TAU (Treatment as Usual)	TAU (Treatment As Usual)	The treatment of the group TAU (Treatment As Usual) will consist of the usual care proposed by every service of the various inquiring centers involved. No additional session will be proposed.

Primary Outcome Measures

Name	Time	Method
Number of worked hours during the first 6 months of the contract of employment	Outcome measures are daily assessed during 6 months (M4 to M9)	Compared evolution in both arms (RECOS and TAU) of the number of worked hours, with regard to the number of hours planned in the contract of employment, during the 6 months following the entry in sheltered working environment (i.e. an external, validated and strong measure of the capacity of the patient to fit professionally).

Secondary Outcome Measures

Name	Time	Method
Compared evolution of the neuropsychological and clinical balance sheets between the beginning and the end of the Cognitive Remediation period (or the end of the "Treatment As Usual" period for the TAU arm)	Scores are assessed 3 times: at M0 (Inclusion), at M3 (after Cognitive Remediation or Treatment As Usual), and at M9 (6 month after end of treatment).	Compared evolution, in both arms (RECOS and TAU) of the scores obtained in the different neuropsychological tests, and in the scales of clinical symptomatology (PANSS, questionnaires of insight, self-respect, well being, social autonomy, and cognitive complaint) at the moment of the inclusion (month M0), early after the training period of Cognitive Remediation or Treatment as Usual (M3), and 6 month after (M9).
Compared evolution of the neuropsychological and clinical balance sheets during the 6 first months of working contract (i.e. following the end of the training Cognitive Remediation period or after the "Treatment As Usual" period for the TAU arm).	Neuropsychological and clinical scores are assessed twice : at M3 (after Cognitive Remediation or Treatment As Usual), and at M9 (after 6 months of working period). Occupational integration (EATR) is assessed twice at the same moments (M3 & M9).	Compared evolution, in both arms (RECOS and TAU) of the scores obtained in the different neuropsychological tests, and in the scales of occupational integration (EATR), clinical symptomatology (PANSS, questionnaires of insight, self-respect, well being, social autonomy, and cognitive complaint) after the training period of Remediation and at the moment of the entry in sheltered working environment (month M3), and 6 months later (month M9).

Trial Locations

Locations (12)

Centre Hospitalier de St-Egrève; 🇫🇷 Saint-Egrève, France

Centre de Santé Mentale Angevin (CESAME); 🇫🇷 Sainte-Gemmes-sur-Loire, France

Tours University Hospital; 🇫🇷 Tours, France

Centre Hospitalier Henri Laborit; 🇫🇷 Poitiers, France

Saint-Cyr Hospital; 🇫🇷 Saint-Cyr-au-Mont-d'Or, France

Hôpital Le Vinatier Pôle Centre; 🇫🇷 Bron, France

Hôpital Le Vinatier Pôle Est; 🇫🇷 Bron, France

Mental Health Center (MGEN); 🇫🇷 Rueil-Malmaison, France

Hôpital Ste Marguerite; 🇫🇷 Marseille, France

Nantes University Hospital; 🇫🇷 Nantes, France

Centre Hospitalier de Niort; 🇫🇷 Niort, France

Hôpital Ste Anne; 🇫🇷 Paris, France